Victory Capital Management Inc. boosted its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 14.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 96,832 shares of the company's stock after acquiring an additional 11,872 shares during the period. Victory Capital Management Inc. owned about 0.53% of Addus HomeCare worth $12,138,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Quarry LP acquired a new position in Addus HomeCare in the third quarter valued at $28,000. Smartleaf Asset Management LLC increased its stake in shares of Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after acquiring an additional 366 shares during the period. Parkside Financial Bank & Trust boosted its position in shares of Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after acquiring an additional 148 shares during the last quarter. Finally, KBC Group NV boosted its position in shares of Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after acquiring an additional 268 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Addus HomeCare Trading Up 3.4 %
ADUS stock traded up $3.11 during trading on Monday, reaching $93.39. The stock had a trading volume of 191,773 shares, compared to its average volume of 146,931. The firm has a fifty day moving average price of $115.30 and a 200 day moving average price of $123.17. The company has a market capitalization of $1.70 billion, a P/E ratio of 21.37, a PEG ratio of 1.41 and a beta of 0.97. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to analysts' expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Sell-side analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current year.
Insider Buying and Selling at Addus HomeCare
In other news, CEO R Dirk Allison sold 25,000 shares of the company's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 4.60% of the stock is currently owned by insiders.
Analysts Set New Price Targets
A number of equities analysts have weighed in on the stock. JMP Securities started coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an "outperform" rating and a $150.00 price target on the stock. Oppenheimer upped their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Macquarie reiterated an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a report on Thursday, February 27th. Stephens restated an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, StockNews.com downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $132.78.
View Our Latest Research Report on Addus HomeCare
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
